Effects of monoclonal antibodies against amyloid-B on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease - Avgerinos, KI; Ferrucci, L; Kapogiannis, D (Ageing Res Rev, 2021)